» Articles » PMID: 26872761

Use of Ulipristal Acetate for the Management of Fibroid-Related Acute Abnormal Uterine Bleeding

Overview
Publisher Elsevier
Date 2016 Feb 14
PMID 26872761
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Episodes of acute abnormal uterine bleeding related to uterine fibroids can cause significant morbidity. Traditional management with high-dose hormonal regimens may not be as effective when used in women with fibroids.

Case: A 32-year-old woman with a 12 cm uterine fibroid presented with an episode of acute abnormal uterine bleeding requiring blood transfusion. In lieu of using a hormonal maintenance regimen after the bleeding had stabilized, the patient was treated with ulipristal acetate 5 mg daily for three months. Amenorrhea was induced rapidly and the patient had no further episodes of acute excessive uterine bleeding. She subsequently underwent a laparoscopic myomectomy with a satisfactory outcome.

Conclusion: Ulipristal acetate has been shown to induce amenorrhea rapidly in women with uterine fibroids, and it can be a useful treatment in the emergency management of fibroid-related acute abnormal uterine bleeding.

Citing Articles

Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.

Liang B, Wu L, Xu H, Cheung C, Fung W, Wong S Reprod Biol Endocrinol. 2018; 16(1):32.

PMID: 29615065 PMC: 5883298. DOI: 10.1186/s12958-018-0347-9.